Loading...
XJPX3401
Market cap1.62bUSD
Dec 27, Last price  
1,327.00JPY
1D
0.99%
1Q
-8.89%
Jan 2017
-43.98%
Name

Teijin Ltd

Chart & Performance

D1W1MN
XJPX:3401 chart
P/E
24.12
P/S
0.25
EPS
55.01
Div Yield, %
2.07%
Shrs. gr., 5y
-1.74%
Rev. gr., 5y
3.05%
Revenues
1.03t
+1.38%
908,389,000,000938,082,000,0001,009,586,000,0001,036,624,000,000943,409,000,000765,840,000,000815,655,000,000854,370,000,000745,712,000,000784,424,000,000786,171,000,000790,748,000,000741,291,000,000834,985,000,000888,589,000,000853,746,000,000836,512,000,000926,054,000,0001,018,751,000,0001,032,773,000,000
Net income
10.60b
P
9,159,000,000924,853,000,00034,124,000,00012,613,000,000-42,963,000,000-35,683,000,00025,182,000,00011,979,000,000-29,130,000,0008,356,000,000-8,086,000,00031,090,000,00050,133,000,00045,556,000,00045,057,000,00025,252,000,000-6,662,000,00023,158,000,000-17,695,000,00010,599,000,000
CFO
69.45b
+26.08%
73,313,000,00075,491,000,00096,455,000,00053,740,000,00040,391,000,00080,432,000,00077,132,000,00053,668,000,00064,305,000,00038,586,000,00076,030,000,00080,640,000,00079,040,000,00080,091,000,00080,899,000,00094,214,000,000107,729,000,00089,656,000,00055,086,000,00069,451,000,000
Dividend
Mar 28, 20250 JPY/sh
Earnings
Feb 06, 2025

Profile

Teijin Limited engages in the fibers, films and sheets, composites, healthcare, and IT businesses worldwide. It offers aramid fibers and polyethylene materials; carbon fibers, composite materials, and oxidized PAN fibers; polycarbonate sheets and films; high-density polyethylene porous films and materials; and microporous films. The company also provides PC resins, polyphenylene sulfide resins, molded parts, and additives; lightweight glass and carbon fiber reinforced composites for automotive applications; and polytrimethylene telephthalate products, artificial leather materials, polyester nanofibers, and recycled polyester fibers. In addition, it offers pharmaceuticals for bone and joint, respiratory, cardiovascular and metabolic, and other diseases; home oxygen therapy, non-invasive positive pressure ventilation, rehabilitation, and sleep disordered breathing related devices, as well as sonic accelerated fracture healing system and community-based integrated care system; and orthopedic implantable devices, and functional food ingredients. Further, the company provides Recopic, a radio-frequency identification technology for inventory management. Additionally, it develops and implements engineering solutions for various issues, such as environmental pollution, energy supply stability, and aging-related workforce population decline. Teijin Limited was incorporated in 1918 and is headquartered in Tokyo, Japan.
URL
https://www.teijin.co.jp/
IPO date
May 16, 1949
Employees
22,484
Domiciled in
JP
Incorporated in
JP

Valuation

Title
JPY in thousands, except ratios and share amounts
FYFYFYFYFYFYFYFYFYFY
2024‑032023‑032022‑032021‑032020‑032019‑032018‑032017‑032016‑032015‑03
Income
Revenues
1,032,773,000
1.38%
1,018,751,000
10.01%
926,054,000
10.70%
Cost of revenue
990,390,000
976,516,000
852,095,000
Unusual Expense (Income)
NOPBT
42,383,000
42,235,000
73,959,000
NOPBT Margin
4.10%
4.15%
7.99%
Operating Taxes
14,795,000
14,337,000
18,099,000
Tax Rate
34.91%
33.95%
24.47%
NOPAT
27,588,000
27,898,000
55,860,000
Net income
10,599,000
-159.90%
(17,695,000)
-176.41%
23,158,000
-447.61%
Dividends
(5,292,000)
(10,571,000)
(10,082,000)
Dividend yield
1.95%
3.94%
3.70%
Proceeds from repurchase of equity
(15,000)
56,403,000
121,981,000
BB yield
0.01%
-21.02%
-44.73%
Debt
Debt current
207,069,000
207,897,000
149,709,000
Long-term debt
306,181,000
337,198,000
346,898,000
Deferred revenue
2,000
37,402,000
38,333,000
Other long-term liabilities
51,039,000
9,745,000
9,178,000
Net debt
285,443,000
288,782,000
240,065,000
Cash flow
Cash from operating activities
69,451,000
55,086,000
89,656,000
CAPEX
(65,042,000)
(57,736,000)
(200,476,000)
Cash from investing activities
(46,052,000)
(52,427,000)
(198,375,000)
Cash from financing activities
(43,159,000)
7,180,000
71,113,000
FCF
(24,636,000)
(32,598,000)
(25,029,000)
Balance
Cash
125,921,000
142,780,000
134,480,000
Long term investments
101,886,000
113,533,000
122,062,000
Excess cash
176,168,350
205,375,450
210,239,300
Stockholders' equity
390,494,000
736,840,000
778,978,000
Invested Capital
852,525,650
813,685,550
778,542,700
ROIC
3.31%
3.50%
8.20%
ROCE
4.10%
4.10%
7.41%
EV
Common stock shares outstanding
192,550
192,243
200,066
Price
1,410.00
1.00%
1,396.00
2.42%
1,363.00
-28.53%
Market cap
271,495,500
1.16%
268,371,228
-1.58%
272,689,958
-25.51%
EV
584,286,500
959,190,228
942,375,958
EBITDA
121,268,000
117,153,000
142,775,000
EV/EBITDA
4.82
8.19
6.60
Interest
10,782,000
7,084,000
3,252,000
Interest/NOPBT
25.44%
16.77%
4.40%